Vetter Pharma-Fertigung GmbH & Co. KG

Greenhouse gas emissions & sustainability report data

📊 Latest report period: 2023🗂️ Report periods on file: 2023, 2022

In its 2023 reporting, Vetter Pharma-Fertigung GmbH & Co. KG disclosed greenhouse gas emissions of 17.9K t CO2e (Scope 1) + 3613 t CO2e (Scope 3). By scope: Scope 1: 17.9K t CO2e/year; Scope 2: 0 t CO2e/year; Scope 3: 3.6K t CO2e/year. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.

💨
GHG Emissions
17.9K t CO2e (Scope 1) + 3613 t CO2e (Scope 3)
2023
💧
Water Usage
495.8K m3/year
2023
♻️
Waste
2.4K tons/year
2023
⚙️
Energy Use
160.8M kWh/year
2023

📊 Emissions by Scope (2023)

ScopeWhat it coversReported value
Scope 1Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions).17.9K t CO2e/year
Scope 2Indirect emissions from purchased electricity, steam, heat and cooling.0 t CO2e/year
Scope 3Other indirect emissions across the value chain (purchased goods, business travel, use of sold products, etc.).3.6K t CO2e/year

New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.

📈 Emissions by Report Period

Report periodHeadline emissions figure reported
202317.9K t CO2e (Scope 1) + 3613 t CO2e (Scope 3)
202224.0K tCO2e (offset through certificate purchases)

Each row is the headline figure extracted from a different report; scope coverage and methodology can change between years.

✅ Reported Environmental Achievements

🎯 Climate & Sustainability Targets

🔜 Short-term

  • Reduce energy consumption by 10% relative to GVA by 2029 (base year 2019).

📅 Medium-term

  • Reduce CO2 emissions by 4.2% annually by 2030; net zero emissions in scopes 1 and 2 by 2040 at German sites; net zero emissions in all scopes by 2050.

🔭 Long-term

  • Net zero emissions by 2050.

🌱 ESG Focus Areas

EnvironmentSocialGovernance

⚠️ Challenges & Risks +

  • Cyberattacks targeting pharmaceutical companies.
  • Security of supply due to energy transition and fluctuating renewable energy generation.
  • Risks in supply chains due to global crises and conflicts.
  • Difficulty in reducing wastewater and using recycled materials in primary packaging due to regulatory requirements.

📋 Report Information

Reporting Period: 2023
Frameworks: GRI, German Sustainability Code (GSC)